PAVmed Financials - Benzinga

PAVmed Inc

PAVMNASDAQ

Trade with Public

Trade with Public

$5.35

0.367.21%

At close: Sep 2, 5:00 PM EST

$5.36

0.010.19%

After Hours: 4:11 PM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare Stock Report

PAVmed Financials

PAVmed (PAVM) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
PAVmed Q2 Adj. EPS $(0.27) Beats $(0.58) Estimate, Sales $33.000K Miss $72.000K Estimate

PAVmed (NASDAQ:PAVM) reported quarterly losses of $(0.27) per share which beat the analyst consensus estimate of $(0.58) by 53.45 percent. This is a 82 percent increase over losses of $(1.50) per share from the same

Benzinga Newsdesk

PRO
PAVmed Q1 Adj. EPS $(1.17) Misses $(0.70) Estimate, Sales $22.000K Miss $74.000K Estimate.

PAVmed (NASDAQ:PAVM) reported quarterly losses of $(1.17) per share which missed the analyst consensus estimate of $(0.70) by 67.14 percent. This is a 44.29 percent increase over losses of $(2.10) per share from the same

Benzinga Newsdesk

Earnings Scheduled For May 15, 2026

Benzinga Insights

PRO
PAVmed Q4 2025 Adj. EPS $(1.05) Beats $(4.62) Estimate, Sales $52.000K Beat $25.000K Estimate

Benzinga Newsdesk

Earnings Scheduled For March 30, 2026

Benzinga Insights

Nasdaq Edges Lower; Johnson & Johnson Earnings Top Estimates

Avi Kapoor